Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Schizophrenia Bulletin|September 18, 2013
Common variants on Xq28 conferring risk of schizophrenia in Han ChineseEmily H M Wong, Hon-Cheong So, Miaoxin Li, et al.
Psychotherapy and Psychosomatics|September 14, 2017
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for PsychosisJessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, et al.
Schizophrenia Research|July 15, 2019
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy peopleAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Research|March 16, 2020
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trialSumudu Rasangi Mallawaarachchi, G Paul Amminger, John Farhall, et al.
Schizophrenia Research|October 14, 2019
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosisAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
The Lancet Regional Health. Western Pacific|September 1, 2023
Prevalence, time trends, and correlates of major depressive episode and other psychiatric conditions among young people amid major social unrest and COVID-19 in Hong Kong: a representative epidemiological study from 2019 to 2022Stephanie M Y Wong, Eric Y H Chen, Y N Suen, et al.
JAMA Psychiatry|May 26, 2018
Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regressionChristoph U Correll, Britta Galling, Aditya Pawar, et al.
Schizophrenia Bulletin Open|August 15, 2024
Twelve-Month Cognitive Trajectories in Individuals at Ultra-High Risk for Psychosis: A Latent Class AnalysisKelly Allott, Stefanie J Schmidt, Hok Pan Yuen, et al.
Schizophrenia Research|September 3, 2013
Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosisChristy L M Hui, Gloria H Y Wong, Jennifer Y M Tang, et al.
Brain, Behavior, and Immunity|March 28, 2022
Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trialSubash Raj Susai, David Mongan, Colm Healy, et al.
Pageof 16